These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23156880)

  • 61. [Secondary prevention after stroke: healthy life style, oral anticoagulation].
    Audebert H; Haberl RL
    MMW Fortschr Med; 2003 May; 145 Suppl 2():61-4. PubMed ID: 14579487
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Prevention, diagnosis and therapy of stroke: time is brain!].
    Stiefelhagen P
    MMW Fortschr Med; 2003; 145 Suppl 1():suppl i-xiv; quiz xv-xvi. PubMed ID: 12958798
    [No Abstract]   [Full Text] [Related]  

  • 63. Patent foramen ovale and cryptogenic stroke.
    Messé SR; Kent DM
    N Engl J Med; 2013 Jul; 369(1):92-3. PubMed ID: 23833785
    [No Abstract]   [Full Text] [Related]  

  • 64. Patent foramen ovale and cryptogenic stroke.
    Carroll JD; Saver JL;
    N Engl J Med; 2013 Jul; 369(1):91-2. PubMed ID: 23833784
    [No Abstract]   [Full Text] [Related]  

  • 65. Patent foramen ovale and cryptogenic stroke.
    Wood WC; Switchenko JM
    N Engl J Med; 2013 Jul; 369(1):88. PubMed ID: 23822783
    [No Abstract]   [Full Text] [Related]  

  • 66. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
    Rothwell PM; Algra A; Amarenco P
    Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transient ischaemic attacks : new approaches to management.
    Madhavan R; Chaturvedi S
    CNS Drugs; 2003; 17(5):293-305. PubMed ID: 12665389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stroke: LDL and stroke risk—clinical practice or target practice?
    Park JH; Ovbiagele B
    Nat Rev Neurol; 2015 Jan; 11(1):8-9. PubMed ID: 25486876
    [No Abstract]   [Full Text] [Related]  

  • 73. Recurrent Ischemic Stroke: Strategies for Prevention.
    Oza R; Rundell K; Garcellano M
    Am Fam Physician; 2017 Oct; 96(7):436-440. PubMed ID: 29094912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
    Liu F; Tantry US; Gurbel PA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1149-65. PubMed ID: 25873127
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.
    Lutsep H
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1295-303. PubMed ID: 21985542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recommendations on the treatment of hypertension in the secondary prevention of ischemic stroke].
    Sierra C; Castilla-Guerra L; Masjuan J; Gil-Nuñez A; Álvarez-Sabín J; Egocheaga MI; Armario P;
    Hipertens Riesgo Vasc; 2018; 35(4):e11-e18. PubMed ID: 30042028
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tracking trends in secondary stroke prevention strategies.
    Carswell JL; Beard KA; Chevrette MM; Pardue CN; Hess DC; Fagan SC
    Ann Pharmacother; 2004 Feb; 38(2):215-9. PubMed ID: 14742753
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current world literature.
    Curr Opin Cardiol; 2012 Jul; 27(4):441-54. PubMed ID: 22678411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.